# NAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy

> **NCT05698771** · PHASE1 · COMPLETED · sponsor: **Haukeland University Hospital** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)
- **DIETARY_SUPPLEMENT:** nicotinamide mononucleotide
- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)
- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)

## Key facts

- **NCT ID:** NCT05698771
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-17
- **Primary completion:** 2024-03-04
- **Final completion:** 2024-03-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05698771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05698771, "NAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05698771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*